LDR | |
01360cam a2200313 a 4500 |
001 |
|
011345109 |
003 |
|
MiAaHDL |
005 |
|
20110215000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
840123s1983 dcu f000 0 eng c |
010 |
⊔ |
⊔ |
‡a 83602953
|
019 |
⊔ |
⊔ |
‡a10079492
|
035 |
⊔ |
⊔ |
‡asdr-pur1635664
|
035 |
⊔ |
⊔ |
‡asdr-ucr.b20053939
|
035 |
⊔ |
⊔ |
‡a1635664
|
035 |
⊔ |
⊔ |
‡a(OCoLC)10063848
|
040 |
⊔ |
⊔ |
‡aDGPO/DLC
‡cDLC
‡dOCLCQ
|
043 |
⊔ |
⊔ |
‡an-us---
|
049 |
⊔ |
⊔ |
‡aIPL1
|
050 |
0 |
0 |
‡aKF27
‡b.V462 1983b
|
082 |
0 |
⊔ |
‡a363.1/79
‡219
|
086 |
0 |
⊔ |
‡aY 4.V 64/3:98-19
|
110 |
1 |
⊔ |
‡aUnited States.
‡bCongress.
‡bHouse.
‡bCommittee on Veterans' Affairs.
‡bSubcommittee on Oversight and Investigations.
|
245 |
1 |
0 |
‡aStatus of federally conducted agent orange studies :
‡bhearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, House of Representatives, Ninety-eighth Congress, first session, May 3, 1983.
|
260 |
⊔ |
⊔ |
‡aWashington :
‡bU.S. G.P.O. :
‡b[For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office],
‡c1983.
|
300 |
⊔ |
⊔ |
‡aiii, 146 p. ;
‡c24 cm.
|
500 |
⊔ |
⊔ |
‡aItem 1027-A, 1027-B (microfiche).
|
500 |
⊔ |
⊔ |
‡a"Serial no. 98-19."
|
500 |
⊔ |
⊔ |
‡aDistributed to depository libraries in microfiche.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
0 |
‡aVeterans
‡xMedical care
‡zUnited States.
|
650 |
⊔ |
0 |
‡aAgent Orange
‡xPhysiological effect.
|
CID |
⊔ |
⊔ |
‡a011345109
|
DAT |
0 |
⊔ |
‡a20101014203438.0
‡b20110215000000.0
|
DAT |
1 |
⊔ |
‡a20120815064345.0
‡b2020-09-20T17:55:14Z
|
DAT |
2 |
⊔ |
‡a2020-09-20T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-PUR
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-pur1635664
‡apur1
‡bSDR
‡cPUR
‡ppur1.32754078107392
‡sPUR
‡11635664
|
974 |
⊔ |
⊔ |
‡bPUR
‡cPUR
‡d20200920
‡sgoogle
‡upur1.32754078107392
‡y1983
‡rpd
‡qbib
‡tUS fed doc
|
974 |
⊔ |
⊔ |
‡bUC
‡cUCR
‡d20230717
‡sgoogle
‡uuc1.31210024766600
‡y1983
‡rpd
‡qbib
‡tUS fed doc
|